Clinical Trial Update: DPP-IV Inhibition Prior to Development of Diabetes in Patients With Cystic Fibrosis [NA]

View source ↗

Summary

This clinical trial update describes evaluating a DPP-4 inhibitor to prevent diabetes development in patients with cystic fibrosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystic Fibrosis

Drugs mentioned

• DPP-4 inhibitor

Snippet

Sponsor: Ram Weiss | Conditions: Cystic Fibrosis | NA | Status: UNKNOWN